614
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review

, B.A, , Ph.DORCID Icon, , MS.c & , Ph.D
Received 09 Mar 2023, Accepted 10 Jul 2023, Published online: 28 Aug 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

F Schifano, A Vento, N Scherbaum & A Guirguis. (2023) Stimulant and hallucinogenic novel psychoactive substances; an update. Expert Review of Clinical Pharmacology 16:11, pages 1109-1123.
Read now

Articles from other publishers (1)

Jiafang Wang, Yankun Feng, Zhong Qi, Jin Li, Zhijun Chen, Jinming Zhang & Degang Zhu. (2024) The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway. Open Life Sciences 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.